Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
T790M, also known as Thr790Met, is a gatekeeper mutation of the epidermal growth factor receptor (EGFR). The mutation substitutes a threonine (T) with a methionine (M) at position 790 of exon 20, affecting the ATP binding pocket of the EGFR kinase domain. Threonine is a small polar amino acid; methionine is a larger nonpolar amino acid. Rather than…
The analysis highlights Clinical and Overview as prominent areas in the source structure around T790M.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around T790M shows recurring relationship patterns in the source. For example, T790M → ATP, EGFR, EGFR TKI, FDA-approved, In November, NSCLC, Over, Tagrisso, TKI, US FDA. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
egfr mutation threonine methionine atp binding osimertinib polar epidermal growth factor receptor pocket kinase domain small nonpolar inhibitors resistance exon
TTTA extracted 11 structured relationships around T790M. Examples in this analysis include osimertinib can overcome this resistance → instance of → irreversible covalent inhibitors and T790M → related to Clinical → Over. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| osimertinib can overcome this resistance | instance of | irreversible covalent inhibitors | 0.80 | text |
| T790M | related to Clinical | Over | 0.60 | section |
| T790M | related to Clinical | EGFR | 0.60 | section |
| T790M | related to Clinical | TKI | 0.60 | section |
| T790M | related to Clinical | ATP | 0.60 | section |
| T790M | related to Clinical | In November | 0.60 | section |
| T790M | related to Clinical | US FDA | 0.60 | section |
| T790M | related to Clinical | Tagrisso | 0.60 | section |
| T790M | related to Clinical | NSCLC | 0.60 | section |
| T790M | related to Clinical | FDA-approved | 0.60 | section |
| T790M | related to Clinical | EGFR TKI | 0.60 | section |
The concept neighborhoods around T790M bring nearby vocabulary together. In this analysis, examples include Egfr, Epidermal and Factor. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For T790M, one of the stronger structural bridges in this analysis connects T790M with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around T790M to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Clinical & Overview, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — T790M · EN edition · Analysis: TopicsToTalkAbout